Cowen Prime Advisors LLC Bausch Health Companies Inc. Transaction History
Cowen Prime Advisors LLC
- $287 Million
- Q2 2023
A detailed history of Cowen Prime Advisors LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 26 shares of BHC stock, worth $204. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$204% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding BHC
# of Institutions
254Shares Held
254MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$274 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$232 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$208 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$123 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$102 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.85B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...